Silvec
Rockville, US · Founded 2019 · Delaware corporation · 2 known investors
Silvec develops RNA-based therapies to protect trees, vines, and bushes from viral, bacterial, and fungal pathogens. The company's proprietary RNA technology delivers lifetime disease protection to crops and forestry without genetic modification.
Founders & leadership
AS
Anne SimonExecutive Officer
SP
Scott PundsackExecutive Officer
RS
Rafael SimonExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$150KofferedJun 2021 · AgricultureRule 506(b)
▶$150KofferedJun 2021 · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Anne SimonExecutive Officer
- Scott PundsackExecutive Officer
- Rafael SimonExecutive Officer, Director
- Offering amount
- $150K
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3MofferedDec 2020 · AgricultureRule 506(b)
▶$3MofferedDec 2020 · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Anne SimonExecutive Officer
- Rafael SimonExecutive Officer, Director
- Scott PundsackExecutive Officer
- Offering amount
- $3M
- Minimum investment
- $25K
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.